ID   6606PDA
AC   CVCL_HX26
DR   Wikidata; Q54604407
RX   PubMed=21276229;
RX   PubMed=21720167;
RX   PubMed=26322225;
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: C57BL/6 Mist1KrasG12D transgenic.
DI   NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
RX   PubMed=21276229; DOI=10.1186/1471-2407-11-40;
RA   Partecke L.I., Kaeding A., Sendler M., Albers N., Kuhn J.-P.,
RA   Speerforck S., Roese S., Seubert F., Diedrich S., Kuehn S.,
RA   Weiss U.F., Mayerle J., Lerch M.M., Hadlich S., Hosten N.,
RA   Heidecke C.-D., Puls R., von Bernstorff W.;
RT   "In vivo imaging of pancreatic tumours and liver metastases using 7
RT   Tesla MRI in a murine orthotopic pancreatic cancer model and a liver
RT   metastases model.";
RL   BMC Cancer 11:40.1-40.14(2011).
//
RX   PubMed=21720167; DOI=10.1159/000329413;
RA   Partecke L.I., Sendler M., Kaeding A., Weiss F.U., Mayerle J.,
RA   Dummer A., Nguyen T.D., Albers N., Speerforck S., Lerch M.M.,
RA   Heidecke C.-D., von Bernstorff W., Stier A.;
RT   "A syngeneic orthotopic murine model of pancreatic adenocarcinoma in
RT   the C57/BL6 mouse using the Panc02 and 6606PDA cell lines.";
RL   Eur. Surg. Res. 47:98-107(2011).
//
RX   PubMed=26322225; DOI=10.1186/s13578-015-0038-6;
RA   Zechner D., Burtin F., Amme J., Lindner T., Radecke T., Hadlich S.,
RA   Kuhn J.-P., Vollmar B.;
RT   "Characterization of novel carcinoma cell lines for the analysis of
RT   therapeutical strategies fighting pancreatic cancer.";
RL   Cell Biosci. 5:51.1-51.10(2015).
//